US 6133276
Compounds and methods for increasing endogenous levels of corticotropin-releasing factor
expired A61PA61P43/00A61P5/00
Quick answer
US patent 6133276 (Compounds and methods for increasing endogenous levels of corticotropin-releasing factor) held by Neurocrine Biosciences, Inc. expires Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Neurocrine Biosciences, Inc.
- Grant date
- Tue Oct 17 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 65
- CPC classes
- A61P, A61P43/00, A61P5/00